Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fangzheng Yi
Observed names:
Fanchao Yi,
Yi, Fangzheng
Institutions:
AdventHealth Orlando,
AdventHealth
Observed institutions:
Anhui Medical University,
AdventHealth Orlando,
Maastricht University Medical Centre,
First Affiliated Hospital of Anhui Medical University,
AdventHealth,
Charité - Universitätsmedizin Berlin
show all 6
ORCID:
0000-0003-3393-9762
Observed ORCID:
0000-0003-3393-9762
OpenAlex ID:
A5007550677
Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2
2022
·
Dapeng Li
, Anjiang Sun
, et al.
·
Theranostics
·
48
PDF
A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression
2024
·
Weiwei Liu
, Zhao Ding
, et al.
·
Molecular Cancer
·
36
Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients
2021
·
Yi Zhao
, Yujie Liu
, et al.
·
International Immunopharmacology
·
23
Gasdermin D in peripheral nerves: the pyroptotic microenvironment inhibits nerve regeneration
2021
·
Ye Tao
, Fang Wang
, et al.
·
Cell Death Discovery
·
19
PDF
Comprehensive Analysis of mTORC1 Signaling Pathway–Related Genes in the Prognosis of HNSCC and the Response to Chemotherapy and Immunotherapy
2022
·
Zhao Ding
, Hailong Shen
, et al.
·
Frontiers in Molecular Biosciences
·
6
PDF
SEC11A contributes to tumour progression of head and neck squamous cell carcinoma
2023
·
Hailong Shen
, Fangzheng Yi
, et al.
·
Heliyon
·
5
Pescadillo ribosomal biogenesis factor 1 reduction suppresses tumour growth and renders chemosensitivity of head and neck squamous cell carcinoma
2022
·
Dapeng Li
, Changyu Yao
, et al.
·
Cancer Medicine
·
4
Intra-arterial transplantation of autologous mesoangioblasts in m.3243A>G mutation carriers is safe: First phase 1/2 human clinical study
2025
·
Florence H.J. van Tienen
, Janneke G.J. Hoeijmakers
, et al.
·
Molecular Therapy
·
3
Dietary Fat, Inflammation, Circulating Tumor Cells, and Circulating Tumor DNA in Colorectal Cancer Survivors: An Exploratory Cross-Sectional Study
2026
·
Stephanie L.E. Compton
, Eunhan Cho
, et al.
·
Journal of the Academy of Nutrition and Dietetics
·
1
Applications of Tumor Organoids in Head and Neck Diseases
2025
·
Fangzheng Yi
·
Head and Neck Diseases Conflux
Corrigendum to “SEC11A contributes to tumour progression of head and neck squamous cell carcinoma” [Heliyon 9(4) (April 2023) e14958]
2023
·
Hailong Shen
, Fangzheng Yi
, et al.
·
Heliyon
PDF
Show more works
View as search
Works count:
29
Citation count:
145
H-index:
5
I10-index:
4
Year
Topic
Type